Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen Dose Escalation and Metabolism in Breast Cancer
NCT00963209Phase 3Unknown
- Sponsor
- Lausanne University Hospital
- Start
- Jun 2009
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tamoxifen in breast cancer, sponsored by Lausanne University Hospital. Status: unknown.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00963209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00963209.